[Pharmacological studies on a new analgesic drug, 1-(m-methoxyphenyl)-2-dimethylaminomethyl cyclohexanol (1) hydrochloride (K-315). 4. Catecholamine potentiating effects of K-315].
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001792:Blood Platelets / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002394:Catechol O-Methyltransferase / Q000032:analysis; D002395:Catecholamines / Q000494:pharmacology*; D002415:Cats; D003511:Cyclohexanols / Q000494:pharmacology*; D003714:Denervation; D004123:Dimethylamines / Q000494:pharmacology; D004357:Drug Synergism; D004987:Ethers / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology; D008297:Male; D008995:Monoamine Oxidase / Q000032:analysis; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects
D000700:Analgesics; D002395:Catecholamines; D003511:Cyclohexanols; D004123:Dimethylamines; D004987:Ethers; D012110:Reserpine; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase; D009638:Norepinephrine